Skip to main content
Premium Trial:

Request an Annual Quote

Opportunities in India

Within India's growing biotech industry, "most jobs are currently available in the private sector and for research and development, marketing, sales/business development, and customer support," The Economic Times reports. Covering a recent talk given by Novozyme's GS Krishnan, vice president of the firm's India/Bangalore presence, The Economic Times adds that "demand at the entry level in the biotechnology industry may not be encouraging [as] the industry is still at a nascent stage in India." Still, according to Krishnan, "career opportunities in fields such as bio-pharmacy, bio-service, bio-agriculture, bio-industrial and bio-informatics is burgeoning."

During the same session, Merck Serono's Lawrence Ganti, general manager/country head for India, said that "many pharmaceutical companies have established R&D centers in India and are considering tapping India's talent." He adds that "graduates with good academic results, relevant experience, and strong soft skills can look forward to a range of positions in the field."

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.